Jeff Keelan

Jeff Keelan gained his PhD from the University of Auckland in 1994, moving from Auckland to Perth WA in 2007. Although his research was initially in the field of steroid biochemistry, where he specialised in assay development, his postdoctoral research has primarily focused on the study of the immunology, endocrinology and pharmacology of pregnancy. He is Professor of Obstetrics and Head of School of Biomedical Sciences at QEII Medical Centre, Perth. He is also Director of the Women and Newborn Health Research Network at King Edward Memorial Hospital. He has supervised more than 50 postgraduate students and published more than 220 articles in the fields of immunology, pharmacology, obstetrics and endocrinology (Google Scholar: >11,000 citations; h-index 61); he has received more than $18 M in competitive grant funding.His current research is centred on the pharmacological treatment of intra-amniotic infection/inflammation, nanoparticle-based drug delivery in pregnancy, the intrauterine microbial and endocrine environment, amniotic fluid metagenomics, lipidomics and toxicology.